1)佐藤浩一:小児バセドウ病の診断と治療.Medical Practice 28:1991-1995,2011
2)佐藤浩一・他:小児期発症バセドウ病薬物治療のガイドライン2008.日本小児科学会雑誌2008 112:946-952,2008
3)日本小児内分泌学会・日本甲状腺学会:小児期発症バセドウ病薬物治療のガイドライン2016.http://www.japanthyroid.jp/img/Basedow_gl2016.pdf
4)Sugino K, et al:Surgical treatment of Graves' disease in children. Thyroid 14:447-452, 2004
5)Sugino, et al:Preoperative change of thyroid stimulating hormone receptor antibody level:possible marker for predicting recurrent hyperthyroidism in patients with Grave's disease after subtotal thyroidectomy. World J Surg 20:801-807, 1996
6)高橋清仁:チアマゾール(MMI),プロピールチオウラシル(PTU)のいずれにも薬物性血小板減少症をきたしたバセドウ病の1例.日内会誌80:276-277,1991
7)Harinder, et al:Primary immune thrombocytopenia responding to antithyroid treatment in a patient with Graves' disease. Ann Hematol 90:223-224, 2011
8)Kurata Y, et al:Thrombocytopenia in Graves' disease:effect of T3 on platelet kinetics. Acta Haematol 63:185-190, 1980
9)小松則夫:自己免疫疾患:診断と治療の進歩Ⅲ-1.特発性血小板減少性紫斑病(免疫性血小板減少症).日内会誌103:1593-1598,2014
10)Grumet FC, et al:HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab 39:1115-1119, 1976
11)Porges A, et al:Elevation of platelet associated antibody levels in patients with chronic idiopathic thrombocytopenic purpura expressing the B8 and/or DR3 allotypes. Tissue Antigens. 26:132-7, 1985
12)白幡 聡・他:小児特発性血小板減少性紫斑病 診断・治療・管理ガイドライン.日小血会誌18:210-218,2004